Knight Therapeutics (04K.MU) Q1 2026 Earnings

19MarConfirmed
Q1 2026
-0
0.02
0.04
0.06

Details

Expected EPS
-0.002516105768
Actual EPS
0.05661237978
Surprise EPS
0.06
Surprise Percent
+2,350%

Description

Knight Therapeutics (04K.MU) has reported earnings of 0.05661237978 per share for Q1 2026.

0 Comments

Share your thoughts